v3.24.3
Stock-Based Compensation (Tables)
 9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense
A summary of stock-based compensation expense recognized in the condensed consolidated statements of operations and comprehensive loss is as follows (in thousands):
Three Months Ended
September 30,		Nine Months Ended
September 30,
2024202320242023
Cost of revenue$102 $9 $714 $16 
Research and development14,641 1,706 57,619 5,057 
Sales and marketing16,200 691 81,216 1,386 
General and administrative14,592 305 46,821 921 
Total$45,535 $2,711 $186,370 $7,380 
Schedule of Stock Option Activity
A summary of stock option activity under the 2018 Plan and 2024 Plan is as follows (in thousands, except years and per share data):
Number of
Shares		Weighted
Average
Exercise
Price		Weighted Average Remaining Contractual Term (in years)Aggregate
Intrinsic
Value
Outstanding at December 31, 202310,059$0.84 7.5$175,790 
Granted70.01 
Exercised(2,006)0.74 
Cancelled and forfeited(80)0.87 
Outstanding at September 30, 20247,980$0.87 6.7$411,107 
Vested and Exercisable at September 30, 20246,004$0.75 6.6$311,037 
Schedule of Restricted Stock Unit Activity
A summary of RSU activity under the 2018 Plan and 2024 Plan is as follows (in thousands, except per share data):
Number of
Restricted Stock
Units		Weighted
Average Grant
Date Fair Value
Outstanding at December 31, 20238,583$13.34 
Granted9,69732.51 
Vested(4,434)12.60 
Cancelled and forfeited(333)29.47 
Outstanding at September 30, 202413,513$26.94